Signature Equity Partners »

SPDR S&P Pharmaceuticals shares owned by Signature Equity Partners

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Signature Equity Partners from 13F filings

Historical chart of Signature Equity Partners investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Signature Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Signature Equity Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3k 19 66.26

More positions owned by Signature Equity Partners

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Federated Hermes Etf Trust Tota Retu Bd Etf (FTRB)
Ishares Tr Russell 2000 Etf (IWM)
Boeing Company (BA)
Microsoft Corporation (MSFT)
Ab Active Etfs Disruptors Etf (FWD)
Tesla Motors (TSLA)
Uwm Holdings Corporation Com Cl A (UWMC)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Signature Equity Partners

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Susquehanna International
Branch Banking & Trust Company
Cetera Investment Advisers
Private Advisor
Two Sigma Investments
Citigroup

View all funds holding SPDR S&P Pharmaceuticals